Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 15, 2019

Primary Completion Date

December 21, 2019

Study Completion Date

December 27, 2019

Conditions
Healthy Volunteer
Interventions
BIOLOGICAL

Biocon Insulin N

Biocon Insulin N is an intermediate-acting isophane suspension of human insulin produced by recombinant deoxyribonucleic acid(rDNA) technology utilizing Pichia pastoris (yeast).

BIOLOGICAL

Humulin® N

Humulin® N (human insulin \[recombinant deoxyribonucleic acid origin\] isophane suspension) is an intermediate-acting human isophane insulin. Humulin® N is a suspension of crystals produced from combining human insulin and protamine sulphate.

Trial Locations (1)

Unknown

Profil Institut für Stoffwechselforschung GmbH, Neuss

All Listed Sponsors
collaborator

Profil Institut für Stoffwechselforschung GmbH

INDUSTRY

lead

Biocon Limited

INDUSTRY

NCT04022304 - Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N | Biotech Hunter | Biotech Hunter